SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients
Clinical trial NCT04067115 · COMPLETED
Trial details
- NCT number
- NCT04067115
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-05
- Primary completion
- 2025-04-24
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.